{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:17:53Z","timestamp":1765545473043,"version":"3.44.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.neuropharm.2007.10.021","type":"journal-article","created":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:59:44Z","timestamp":1196470784000},"page":"521-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["AM404, an anandamide transport inhibitor, reduces plasma extravasation in a model of neuropathic pain in rat: Role for cannabinoid receptors"],"prefix":"10.1016","volume":"54","author":[{"given":"G.","family":"La Rana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"D'Agostino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Sasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Mattace","family":"Raso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Iacono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Meli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Piomelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Calignano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2007.10.021_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0304-3959(93)90134-B","article-title":"Skin vascular reactivity to the neuropeptide substance P in rats with peripheral mononeuropathy","volume":"52","author":"Basile","year":"1993","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2007.10.021_bib2","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.277.5329.1094","article-title":"Functional role of high-affinity anandamide transport, as revealed by selective inhibition","volume":"277","author":"Beltramo","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2007.10.021_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2007.10.021_bib4","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1096\/fj.05-4743fje","article-title":"Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice","volume":"20","author":"Bilsland","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2007.10.021_bib5","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1074\/jbc.272.6.3315","article-title":"Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes","volume":"272","author":"Bisogno","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2007.10.021_bib6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.bjp.0704110","article-title":"The synthetic cannabinoid WIN 55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain","volume":"133","author":"Bridges","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.10.021_bib7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0306-4522(03)00200-8","article-title":"Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry","volume":"119","author":"Bridges","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.10.021_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1476-5381.1992.tb14321.x","article-title":"Cannabinoid receptor agonists inhibit Ca++ current in NG108-neuroblastoma cells via a pertussis toxin-sensitive mechanism","volume":"106","author":"Caulfield","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.10.021_bib9","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/sj.bjp.0706798","article-title":"AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulate cytokine and apoptotic pathways in a rat model of neuropathic pain","volume":"148","author":"Costa","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.10.021_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/neu.20080","article-title":"The endogenous cannabinoid system and its role in nociceptive behaviour","volume":"61","author":"Cravatt","year":"2004","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.neuropharm.2007.10.021_bib11","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/372686a0","article-title":"Formation and inactivation of endogenous cannabinoid anandamide in central neurons","volume":"372","author":"Di Marzo","year":"1994","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neuropharm.2007.10.021_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/MOL.0b013e32803dbdec","article-title":"Endocannabinoids and the regulation of their levels in health and disease","volume":"18","author":"Di Marzo","year":"2007","journal-title":"Curr. Opin. Lipidol"},{"key":"10.1016\/j.neuropharm.2007.10.021_bib13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0165-6147(94)90147-3","article-title":"Pharmacology of chronic pain","volume":"15","author":"Dray","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2007.10.021_bib14","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ejpain.2006.07.006","article-title":"Ameliorative effect of combined administration of inducible nitric oxide synthase inhibitor with cyclooxygenase-2 inhibitors in neuropathic pain in rats","volume":"11","author":"Dudhgaonkar","year":"2007","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2007.10.021_bib15","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1111\/j.1460-9568.2004.03690.x","article-title":"Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naive rats and in rat models of inflammatory and neuropathic pain","volume":"20","author":"Elmes","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2007.10.021_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3565(24)29345-9","article-title":"Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology","volume":"298","author":"Giuffrida","year":"2001","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.neuropharm.2007.10.021_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3940(95)11289-9","article-title":"Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes","volume":"186","author":"Henry","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2007.10.021_bib18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(96)13308-5","article-title":"The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain","volume":"221","author":"Herzberg","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2007.10.021_bib19","doi-asserted-by":"crossref","first-page":"10529","DOI":"10.1073\/pnas.1834309100","article-title":"Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS","volume":"100","author":"Ibrahim","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.neuropharm.2007.10.021_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0304-3959(90)90054-H","article-title":"Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia","volume":"43","author":"Joris","year":"1990","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2007.10.021_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2004.06.011","article-title":"Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors","volume":"496","author":"Kelley","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.10.021_bib22","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1124\/jpet.105.100792","article-title":"Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404","volume":"317","author":"La Rana","year":"2006","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.neuropharm.2007.10.021_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0304-3940(98)00982-3","article-title":"Local expression of inducible nitric oxide synthase in an animal model of neuropathic pain","volume":"260","author":"Levy","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2007.10.021_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0166-2236(93)90092-Z","article-title":"Nerve growth factor and nociception","volume":"16","author":"Lewin","year":"1993","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2007.10.021_bib25","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1460-9568.2002.01940.x","article-title":"Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain","volume":"15","author":"Ma","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.10.021_bib26","doi-asserted-by":"crossref","first-page":"13484","DOI":"10.1074\/jbc.275.18.13484","article-title":"Anandamide uptake by human endothelial cells and its regulation by nitric oxide","volume":"275","author":"Maccarrone","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2007.10.021_bib27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pain.2006.06.016","article-title":"Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain","volume":"126","author":"Mitrirattanakul","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2007.10.021_bib40","first-page":"240","article-title":"Immune and inflammatory mechanisms in neuropathic pain. Brain Res","volume":"51","author":"Moalem","year":"2006","journal-title":"Rev."},{"key":"10.1016\/j.neuropharm.2007.10.021_bib28","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0306-4522(03)00126-X","article-title":"Selective activation of\u00a0cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation","volume":"119","author":"Nackley","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.10.021_bib29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0006-8993(03)02808-7","article-title":"Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain","volume":"978","author":"Nicholson","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2007.10.021_bib30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuropharm.2006.08.011","article-title":"Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats","volume":"52","author":"Petrosino","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2007.10.021_bib31","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1006\/nbdi.1998.0221","article-title":"Endogenous cannabinoid signaling","volume":"5","author":"Piomelli","year":"1998","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2007.10.021_bib32","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0022-3565(24)35376-5","article-title":"Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells","volume":"292","author":"Rakhshan","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.neuropharm.2007.10.021_bib33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0304-3959(97)00213-3","article-title":"Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors","volume":"75","author":"Richardson","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2007.10.021_bib34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0306-4522(96)00127-3","article-title":"Schwann cells produce tumor necrosis factor alpha: expression in injured and non injured nerves","volume":"73","author":"Wagner","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.10.021_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0006-8993(85)90412-3","article-title":"Release of substance P from peripheral nerve terminals following electrical stimulation of the sciatic nerve","volume":"336","author":"White","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2007.10.021_bib36","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/j.1471-4159.2004.02544.x","article-title":"Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice","volume":"89","author":"Witting","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2007.10.021_bib37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0304-3959(01)00264-0","article-title":"Influence of painful chronic neuropathy on neurogenic inflammation","volume":"92","author":"Yonehara","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2007.10.021_bib38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2007.10.021_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(00)00207-7","article-title":"The anandamide transport inhibitor AM404 activates vanilloid receptors","volume":"396","author":"Zygmunt","year":"2000","journal-title":"Eur. J. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807003504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807003504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:36:53Z","timestamp":1758436613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390807003504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0028390807003504"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2007.10.021","relation":{},"ISSN":["0028-3908"],"issn-type":[{"type":"print","value":"0028-3908"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AM404, an anandamide transport inhibitor, reduces plasma extravasation in a model of neuropathic pain in rat: Role for cannabinoid receptors","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2007.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}